Cargando…
Clinical and analytical evaluation of the Abbott AdviseDx quantitative SARS-CoV-2 IgG assay and comparison with two other serological tests
INTRODUCTION: Serological testing is an important tool to assist with assessing the immune response to SARS-CoV-2 infections, the causative agent of COVID-19. A quantitative assay was recently developed by Abbott Laboratories to measures antibodies against the receptor binding domain of the spike pr...
Autores principales: | Maine, Gabriel N., Krishnan, Subhashree Mallika, Walewski, Kelly, Trueman, Jillian, Sykes, Elizabeth, Sun, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847080/ https://www.ncbi.nlm.nih.gov/pubmed/35181288 http://dx.doi.org/10.1016/j.jim.2022.113243 |
Ejemplares similares
-
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
por: Maine, Gabriel N., et al.
Publicado: (2020) -
Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity
por: Bradley, Benjamin T., et al.
Publicado: (2021) -
Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patients
por: Jugwanth, Sarika, et al.
Publicado: (2022) -
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
por: Batra, Rahul, et al.
Publicado: (2020) -
Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)